Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06629077

Brain Blood Vessel Responses to Changes in Blood Flow

Brain blood flow will be measured during a simulated postural change test and while breathing increased levels of carbon dioxide using magnetic resonance imaging.

Recruiting

Interested in participating?

Request Info

Key information

Age range

55 year–69 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Wisconsin

Madison, Wisconsin, 53705, United States

Location status: Recruiting

Location contact

Anna J Howery, MS

CONTACT

[email protected]

608-262-9572

Jill N Barnes, PhD

PRINCIPAL_INVESTIGATOR

About this study

Global cerebral blood flow (CBF) decreases with advancing age; however, some adults have accelerated declines in CBF, placing them at a greater risk of cognitive impairment. However, there is a lack of human studies that investigate the cause or consequence of altered blood flow regulation in the brain. This study will systematically address this gap in knowledge by examining cerebrovascular control in adults during acute physiological challenges (simulated postural change test and breathing increased carbon dioxide) that stimulate a change in CBF.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 55-69 years
  • Have a BMI less than or equal to 34.5 kg/m2
  • Nonsmoker
  • are less than 72 in (182.88 cm) height
  • Females must be postmenopausal

Exclusion criteria

  • Diagnosis of Mild Cognitive Impairment (MCI) or Alzheimer's disease (AD)
  • History or evidence of hepatic disease, hematological disease, or peripheral vascular disease; severe kidney injury requiring hemodialysis
  • History of cardiovascular disease including: severe congestive heart failure, coronary artery disease, ischemic heart disease (stents, coronary artery bypass grafts) and tachycardia
  • Uncontrolled hypertension
  • History of clinically significant ischemic or hemorrhagic stroke, or significant cerebrovascular disease
  • Severe untreated obstructive sleep apnea
  • History of diabetes with HbA1c greater than 9.5%
  • Major neurologic disorders other than dementia (e.g., MS, ALS, brain surgery, etc.)
  • Current or recent (<1 year) major psychiatric condition (Axis I) or addictive disorders
  • Significant surgical history
  • Other significant medical conditions at investigators' discretion
  • Contraindications to MRI
  • Prescribed medications that interfere with prazosin
  • Lactose allergy
  • lower body will not fit in lower body negative pressure (LBNP) chamber (regardless of overall height and BMI).

Treatment and study plan

MRI

Device

Participants will undergo an MRI scan while performing breathing and a simulated postural change task.

Prazosin

Drug

A dose of prazosin will be administered based on body weight.

Placebo

Drug

Oral placebo

Primary outcomes

  1. Change in blood flow

    Time frame: Two study visits, up to 240 minutes

    The change in intracranial blood flow during breathing and simulated postural change tasks will be measured with MRI

  2. Change in blood velocity

    Time frame: Two study visits, up to 240 minutes

    The change in blood velocity during breathing and simulated postural change tasks will be measured with MRI.

Study contacts

Contact information is provided by the study sponsor or research team.

Anna Howery

CONTACT

[email protected]

608-262-9572

Sponsors and collaborators

Lead sponsor

University of Wisconsin, Madison

Other

Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

Registry information

Official study title

Cerebrovascular Responses to Acute Hypoperfusion

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Oct 8, 2024
Registry last updated
Mar 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.